Skip to main content

Advertisement

Log in

A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Oxaliplatin, a third-generation platinum agent, has been used for the treatment of colon, pancreatic, and stomach cancers in recent years. It carries a reduced risk of acute kidney injury (AKI) compared to the previous platinum agents, including cisplatin and carboplatin. Several cases of oxaliplatin-induced acute tubular necrosis (ATN) have been reported; however, only one case has been reported as acute tubulointerstitial nephritis (ATIN) histopathologically. Here, we present a case of biopsy-proven and dialysis-dependent ATIN, which dramatically resolved with steroid therapy. The patient was a 67-year-old male who had undergone chemotherapy for colon adenocarcinoma. He suddenly developed shaking chills, fever, and hot flashes at the end of the 18th 5-fluorouracil (5-FU)/l-leucovorin/oxaliplatin administration, and was admitted to our hospital. On the 4th day of hospitalization, severe renal dysfunction (creatinine 6.5 mg/dL) was observed. As oliguria continued, we initiated hemodialysis therapy on the 6th day of hospitalization. Drug-induced ATIN was strongly suspected due to the history of multiple exposures to oxaliplatin with allergic reaction and sterile pyuria. We began steroid therapy on the 8th day of hospitalization. Subsequently, renal biopsy was performed and the diagnosis of ATIN was made. The patient’s renal function gradually improved, and 6 months later, it had returned to baseline. Our case demonstrates that we should consider not only ATN, but also ATIN, as potential presentations of oxaliplatin-induced AKI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.

    Article  PubMed  Google Scholar 

  2. Markman M, Kennedy A, Webster K, et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol. 1999;17:1141–5.

    Article  CAS  PubMed  Google Scholar 

  3. Polyzos A, Tsavaris N, Gogas H, et al. Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience. Oncology. 2009;76:36–41.

    Article  CAS  PubMed  Google Scholar 

  4. Pinotti G, Martinelli B. A case of acute tubular necrosis due to oxaliplatin. Ann Oncol. 2002;13:1951–2.

    Article  CAS  PubMed  Google Scholar 

  5. Phan NT, Heng AE, Lautrette A, et al. Oxaliplatin-induced acute renal failure presenting clinically as thrombotic micro-angiopathy: think of acute tubular necrosis. NDT Plus. 2009;2:254–6.

    PubMed  PubMed Central  Google Scholar 

  6. Filewod N, Lipman ML. Severe acute tubular necrosis observed subsequent to oxaliplatin administration. Clin Kidney J. 2014;7:68–70.

    Article  PubMed  Google Scholar 

  7. Labaye J, Sarret D, Duvic C, et al. Renal toxicity of oxaliplatin. Nephrol Dial Transplant. 2005;20:1275–6.

    Article  CAS  PubMed  Google Scholar 

  8. Joybari AY, Sarbaz S, Azadeh S, et al. Oxaliplatin-induced renal tubular vacuolization. Ann Pharmacother. 2014;48:796–800.

    Article  CAS  PubMed  Google Scholar 

  9. Ashrafi F, Nematbakhsh M, Nasri H, Talebi A, Hosseini SM, Ashrafi M. Vacuolization, dilatation, hyaline cast, debris or degeneration: which one is the most correlated item to score the kidney damage pathologically in cisplatin induced nephrotoxicity model? Nephrourol Mon. 2014;5:918–20.

    Article  Google Scholar 

  10. Yonezawa A, Masuda S, Yokoo S. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther. 2006;319:879–86.

    Article  CAS  PubMed  Google Scholar 

  11. Yokoo S, Yonezawa A, Masuda S, et al. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem Pharmacol. 2007;74:477–87.

    Article  CAS  PubMed  Google Scholar 

  12. Yonezawa A, Inui KI. Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents. Biochem Pharmacol. 2011;81:563–8.

    Article  CAS  PubMed  Google Scholar 

  13. Ito I, Ito Y, Mizuno M, et al. A rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin. Clin Exp Nephrol. 2012;16:490–4.

    Article  CAS  PubMed  Google Scholar 

  14. Muriithi AK, Nasr SH, Leung N. Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol. 2013;8:1857–62.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Koselj M, Kveder R, Bren AF, et al. Acute renal failure in patients with drug-induced acute interstitial nephritis. Ren Fail. 1993;15:69–72.

    Article  CAS  PubMed  Google Scholar 

  16. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59(8):809–20.

    Article  CAS  PubMed  Google Scholar 

  17. Perazella MA. Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician. Clin Nephrol. 2014;81(6):381–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Fiorentino M, Bolignano D, Tesar V, et al. Renal biopsy in 2015—from epidemiology to evidence-based indications. Am J Nephrol. 2016;43:1–19.

    Article  PubMed  Google Scholar 

  19. Praga M, González E. Acute interstitial nephritis. Kidney Int. 2010;77:956–61.

    Article  PubMed  Google Scholar 

  20. Muriithi AK, Leung N, Valeri AM, et al. Biopsy-proven acute interstitial nephritis 1993–2011: a case series. Am J Kidney Dis. 2014;64:558–66.

    Article  PubMed  Google Scholar 

  21. Pierce A, Nester T. Pathology consultation on drug-induced hemolytic anemia. Am J Clin Pathol. 2011;136:7–12.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Editage (http://www.editage.jp) for English language editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masahiko Yazawa.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Human and animal rights

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from the patient described in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamada, S., Yazawa, M., Yamamoto, M. et al. A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia. CEN Case Rep 8, 188–193 (2019). https://doi.org/10.1007/s13730-019-00390-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-019-00390-8

Keywords

Navigation